Effect of Cosmetic Procedures in the Periorbital Area on the Organ of Vision: Overview

Practitioners in ophthalmology in recent years often face the effects of cosmetic procedures on the paraorbital area, as well as directly on the eyelids. Such influences include botox injections in paraorbital area, blepharoplasty, eyelash extensions, injections of various fillers, etc. These manipulations are widely used and often lead to various complications of the vision organ. Eyelash extensions are a popular procedure, especially among urban, young women, but there are potential health risks from the procedure. Tattooing of eyelids leads is the cause of dysfunction of meibomian glands, which can lead to the dry eye syndrome, manifested as complaints about a feeling of chronic discomfort in the eyes. Due to the growing popularity of the age tattoo, it is necessary to pay close attention to the training of specialists who conduct this procedure. The procedure for permanent eyelid make-up should be performed after careful consideration of possible complications, and by special trained professionals. In recent years, various cosmetic procedures for rejuvenating the face plays great role, for example, injections of botulinum toxin, as well as various dermal fillers — the application of which is aimed at eliminating the aging signs. The qualification of the specialist his awareness of the occurrence of possible complications, as well as the awareness of patients who undergo this procedure is an important aspect in the application of botulinum toxin, both for therapeutic and cosmetic purposes. Of great interest are the complications associated with ischemia in the form of soft tissue necrosis and vascular occlusion caused by fillers introduction. It is reported that the frequency of vascular occlusion with dermal fillers is up to 3 per 1000 injections. The only proven elimination of soft tissue ischemia in case of a hyaluronic acid filler use is early high-dose hyaluronidase injections, since this drug helps deactivate the action of hyaluronic acid. Modern ophthalmologic practice is inextricably linked with the latest methods of modern cosmetology medicine, the results of it can effect on the functions of the whole organism as the organ of vision in particular. This fact and the specificity of possible complications arising from cosmetic procedures in the periorbital zone should be taken into account during the anamnesis collecting anamnesis, and examining patients, including preoperative preparation, and in choosing the treatment method.

1. Amano Y, Nishiwaki Y. National survey on eyelash extensions and their related health problems. Nihon Eiseigaku Zasshi. 2013;68(3):168–74.

2. Amano Y., Sugimoto Y., Sugita M. Ocular disorders due to eyelash extensions. Cornea. 2012 Feb;31(2):121–125. DOI: 10.1097/ICO.0b013e31821eea10

3. Abah E.R., Oladigbolu K.K., Rafindadi A.L., Audu O. Eyelash extension use among female students in a Tertiary Institution in Nigeria: A study of Kaduna polytech nic, Kaduna. Niger J Clin Pract. 2017 Dec;20(12):1639–1643. DOI: 10.4103/njcp. njcp_124_17

4. Ullrich K., Saha N. Semipermanent eyelash extensions causing bacterial keratitis: a case report. Can J Ophthalmol. 2013 Jun;48(3):e50–e51. DOI: 10.1016/j. jcjo.2012.12.010

5. Michaels J.P., Macdonald P. Ignition of eyelash extensions during routine minor eyelid surgery. Ophthalmic Plast Reconstr Surg. 2014 May-Jun;30(3):e61–2. DOI: 10.1097/IOP.0b013e31829bb476

6. Dowlut M.S., Ahmed Y., Knox A. Ocular Inflammation Associated With Fibers From Eyelash Extensions. JAMA Ophthalmol. 2018 Jan 11;136(1):e175723. DOI: 10.1001/jamaophthalmol.2017.5723 Epub 2018 Jan 11.

7. Lindström I. , Suojalehto H., Henriks-Eckerman M.L., Suuronen K. Occupational asthma and rhinitis caused by cyanoacrylate-based eyelash extension glues. Occup Med (Lond). 2013 Jun;63(4):294–297. DOI: 10.1093/occmed/kqt020

8. Goldman A., Wollina U. Severe unexpected adverse effects after permanent eye makeup and their management by Q-switched Nd:YAG laser. Clin Interv Aging. 2014 Aug 11;9:1305–1309. DOI: 10.2147/CIA.S67167 eCollection 2014

9. Kligman A.M., Graham J.A. The psychology of appearance in the elderly. Dermatol Clin. 1986;4(3):501–507.

10. Straetemans M., Katz L.M., Belson M. Adverse reactions after permanent-makeup procedures. N Engl J Med. 2007 Jun 28;356(26):2753.

11. De Cuyper C. Permanent makeup: indications and complications. Clin Dermatol. 2008;26(1):30–34.

12. Straetemans M., Katz L.M., Belson M. Adverse reactions after permanent-makeup procedures. N Engl J Med. 2007;356(26):2753.

13. Liao J.C., Proia A.D., Ely P.H., Woodward J.A. Late-onset melanophenic hypomelanosis as a complication of cosmetic eyeliner tattoo. J Am Acad Dermatol. 2013;69(3):e144–e146.

14. Wollina U. Nodular skin reactions in eyebrow permanent makeup: two case reports and an infection by Mycobacterium haemophilum. J Cosmet Dermatol. 2011;10(3):235–239.

15. Giulieri S., Morisod B., Edney T., et al. Outbreak of Mycobacterium haemophilum in fections after permanent makeup of the eyebrows. Clin Infect Dis. 2011;52(4):488–491.

16. Lehner K., Santarelli F., Vasold R., König B., Landthaler M., Bäumler W. Black tattoo inks are a source of problematic substances such as dibutyl phthalate. Contact Dermatitis. 2011;65(4):231–238.

17. Høgsberg T., Jacobsen N.R., Clausen P.A., Serup J. Black tattoo inks induce reactive oxygen species production correlating with aggregation of pigment nanoparticles and product brand but not with the polycyclic aromatic hydrocarbon content. Exp Dermatol. 2013;22(7):464–469.

18. Peters N.T., Conn H., Côté M.A. Extensive lower eyelid pigment spread after blepharopigmentation. Ophthal Plast Reconstr Surg. 1999;15(6):445–447.

19. Tse D.T., Folberg R., Moore K. Clinicopathologic correlate of a fresh eyelid pigment implantation. Arch Ophthalmol. 1985;103(10):1515–1517.

20. Moshirfar M., Espandar L., Kurz C., Mamalis N. Inadvertent pigmentation of the limbus during cosmetic blepharopigmentation. Cornea. 2009;28(6):712–713.

21. Hurwitz J.J., Brownstein S., Mishkin S.K. Histopathological findings in blepharopigmentation (eyelid tattoo). Can J Ophthalmol. 1988 Oct;23(6):267–269.

22. Maier M.J., Flaig T., Ruzicka C., Berking T. Pavicic High‐definition optical coherence tomography and reflectance confocal microscopy in the in vivo visualization of a reaction to permanent make‐up. Journal of the European Academy of Dermatology and Venereology. 2015 Mar;29(3):602–606. DOI: 10.1111/jdv.12402

23. Lee Y.B., Kim J.J., Hyon J.Y., Wee W.R., Shin Y.J. Eyelid Tattooing Induces Meibomian Gland Loss and Tear Film Instability. Cornea. 2015 Jul;34(7):750–755. DOI: 10.1097/ICO.0000000000000452

24. Bo Ram Seol, Ji Won Kwon, Won Ryang Wee and Young Keun Han. A Case of Meibomian Gland Dysfunction after Cosmetic Eyelid Tattooing Procedure. Korean Ophthalmol Soc. 2013 Aug;54(8):1309–1313. Korean. Published online August 14, 2013. DOI: 10.3341/jkos.2013.54.8.1309

25. Kojima T., Dogru M., Matsumoto Y., Goto E., Tsubota K. Tear film and ocular surface abnormalities after eyelid tattooing. Ophthal Plast Reconstr Surg. 2005 Jan;21(1):69–71.

26. De M., Marshak H., Uzcategui N., Chang E. Full-thickness eyelid penetration during cosmetic blepharopigmentation causing eye injury. J Cosmet Dermatol. 2008 Mar;7(1):35–38. DOI: 10.1111/j.1473-2165.2008.00340.x

27. Cruz N.F., Santos K.S., Farah M.L., Felberg S. Conjunctival Tattoo with Inadvertent Globe Penetration and Associated Complications. Cornea. 2017 May;36(5):625– 627. DOI:10.1097/ICO.0000000000001163

28. Vassileva S., Hristakieva E. Medical applications of tattooing. Clinics in Dermatology. 2007 Jul-Aug;25(4):367–374. DOI: 10.1016/j.clindermatol.2007.05.014

29. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):951–957.

30. Lew M.F. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain 2002;18:142–6.

31. Sahlin S, Linderoth Eyelid Botulinum toxin injections for dry eye. Dev Opthalmol. 2008;41:187–92.

32. Başar E., Arıcı C. Use of Botulinum Neurotoxin in Ophthalmology. Turk J Ophthalmol. 2016 Dec;46(6): 282–290. Published online 2016 Dec 1. DOI: 10.4274/ tjo.57701

33. Coté T.R., Mohan A.K., Polder J.A., Walton M.K., Braun M.M. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005 Sep;53(3):407–415.

34. Evidente V.G., Truong D., Jankovic J., Comella C.L., Grafe S., Hanschmann A. IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014 Nov 15;346(1–2):116– 120. DOI: 10.1016/j.jns.2014.08.004

35. Huang X.F., Wang K.Y., Liang Z.H., Du R.R., Zhou L.N. Clinical Analysis of Patients with Primary Blepharospasm: A Report of 100 Cases in China. Eur Neurol. 2015;73(5–6):337–341. DOI: 10.1159/000381707

36. Raj A., Arya S.K., Deswal J., Bamotra R.K. Five-Year Retrospective Review of Cases with Benign Essential Blepharospasm and Hemifacial Spasm Presenting in a Tertiary Eye Care Center in North India. Semin Ophthalmol. 2017;32(3):371–376. DOI: 10.3109/08820538.2015.1096401

37. Isshiki Y., Ishikawa H., Mimura O. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm: BTX improves dry eye in patients with BEB. Jpn J Ophthalmol. 2016 Nov;60(6):486–491. Epub 2016 Aug 8.

38. Stewart K.J., Joseph S.S., Douglas R.S. An Aesthetic Orbicularis Oculi Myectomy Technique for Blepharospasm: Use of Topical 5-Fluorouracil and Fibrin Sealant. Ophthalmic Plast Reconstr Surg. 2017 Aug 24. DOI: 10.1097/IOP.0000000000000992

39. Lennerstrand G., Nordbø O.A., Tian S., et al: Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1998;76:27–7.

40. Valls-Solé J., Montero J. Movement disorders in patients with peripheral facial palsy. Mov Disord. 2003;18:1424–1435.

41. Ellis M.F., Daniell M. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis. Clin Experiment Ophthalmol. 2001 Dec;29(6):394–399.

42. Sahlin S. Linderoth Eyelid Botulinum toxin injections for dry eye. Dev Opthalmol. 2008;41:187–192.

43. Su J.Z., Cai Z.G., Yu G.Y. Microvascular autologous submandibular gland transplantation in severe cases of keratoconjunctivitis sicca. Maxillofac Plast Reconstr Surg. 2015 Feb 5;37(1):5. eCollection 2015 Dec. Review.

44. Bukhari A.A. Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease. Oman J Ophthalmol. 2014 May;7(2):61–65. DOI: 10.4103/0974-620X.137142

45. Serna-Ojeda J.C., Nava-Castaneda A. Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye. Acta Ophthalmol. 2017 Mar;95(2):e132–e137. DOI: 10.1111/aos.13140

46. Mattout H.K. Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study. Ophthalmol Ther. 2017 Jun;6(1):167–174. DOI: 10.1007/s40123-017-0079-5

47. Ricci L.H., Navajas S.V., Carneiro P.R., Söderberg S.A., Ferraz C.A. Ocular adverse effects after facial cosmetic procedures: a review of case reports. J Cosmet Dermatol. 2015 Jun;14(2):145–151. DOI: 10.1111/jocd.12141

48. Маркова Е.Ю., Полунина Е.Г., Иойлева Е.Э. Аллергические заболевания глаз у детей. Современный взгляд на патогенез и лечение. Офтальмология. 2017;14(2):125–129 [Markova E.Y., Polunina E.G., Ioileva E.E. Аllergic eye dis eases in children. modern view on pathogenesis and treatment. Ophthalmology in Russia = Oftal’mologiya. 2017;14(2):125–129 (In Russ.)]. DOI: 10.18008/18165095-2017-2-125-129

49. Каспарова Е.А., Зайцев А.В., Каспарова Е.А., Каспаров А.А. Микродиатер мокоагуляция в лечении инфекционных язв роговицы. Офтальмология. 2016;13(3):157–162 [Kasparova E.A., Zajcev A.V., Kasparova E.A., Kasparov A.A. Мicro diathermocoagulation in the treatment of infectious corneal ulcers. Ophthalmology in Russia = Oftal’mologiya. 2016;13(3):157–162 (In Russ.)]. DOI: 10.18008/1816-5095-2016-3-157-162

50. Gomes J.A.P., Azar D.T., Baudouin C., Efron N., Hirayama M., Horwath-Winter J., Kim T., Mehta J.S., Messmer E.M., Pepose J.S., Sangwan V.S., Weiner A.L., Wilson S.E., Wolffsohn J.S. TFOS DEWS II iatrogenic report. Ocul Surf. 2017 Jul;15(3):511–538. DOI: 10.1016/j.jtos.2017.05.004. Epub 201

51. Carruthers J. et al: The treatment of congenital nystagmus with Botox. J Pediatr Ophthalmol Strabismus. 1995;32:306–308. Review.

52. Levy Y., Kremer I., Shavit S., et al: The pupillary effects of retrobulbar injection of botulinum toxin A (oculinum) in albino rats. Invest Ophthalmol Vis Sci. 1991;32:122–125.

53. Corridan P., Nightingale S., Mashoudi N., et al: Acute angle closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol. 1990;74:309–310.

54. Liu M., Lee H.C., Hertle R.W., Ho A.C. Retinal detachment from inadvertent intraocular injection of botulinum toxin A. Am J Ophthalmol. 2004;137:201–202. 55. Narang P., Singh S., Mittal V. Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection. Indian J Ophthalmol. 2018 May;66(5):697–699. DOI: 10.4103/ijo.IJO_904_17

55. Small R. Botulinum toxin injection for facial wrinkles. Am Fam Physician. 2014 Aug 1;90(3):168–175.

56. Юсупова Л.А., Мингазетдинова Н.И. Современное состояние проблемы су хой кожи. Лечащий Врач. 2014;5:41–46 [Yusupova L.A., Mingazetdinova N.I. The current state of the dry skin problem. Medical Journal = Lechashchij vrach. 2014;5:41–46 (In Russ.)].

57. Farage M.A., Miller K.W., Zouboulis C.C., Piérard G.E., Maybach H.I. Gender dif ferences in skin aging and the changing profile of sex hormones with age. J Steroids Horm Scientific. 2012;3:109.

58. Bernardini F.P., Cetinkaya A., Devoto M.H., Zambelli A. Calcium hydroxyl-apatite (Radiesse) for the correction of periorbital hollows, dark circles, and lower eye lid bags. Ophthal Plast Reconstr Surg. 2014 Jan-Feb;30(1):34–39. DOI: 10.1097/ IOP.0000000000000001

59. Guerrissi J.O. Periorbital rejuvenation: a safe subcutaneous approach to forehead, eyebrow, and orbicularis oculis muscle mobilization. Aesthetic Plast Surg. 2010 Apr;34(2):147–152. DOI: 10.1007/s00266-009-9356-6

60. Beleznay K., Humphrey S., Carruthers J.D., Carruthers A. Vascular compromise from soft tissue augmentation: Experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol. 2014;7:37–43.

61. Beleznay K., Carruthers J.D., Humphrey S., Jones D. Avoiding and treating blindness from fillers: A review of the world literature. Dermatol Surg. 2015;41:1097–1117.

62. Hwang J.C. Periorbital injectables: Understanding and Avoiding Complications. J Cutan Aesthet Surg. 2016 Apr-Jun;9(2):73–79. DOI: 10.4103/0974-2077.184049

63. Xiu Zhuo Hu, Jun Yan Hu, Peng Sen Wu, Sheng Bo Yu, Don O. Kikkawa, Wei Lu. Posterior Ciliary Artery Occlusion Caused by Hyaluronic Acid Injections into the Forehead. Medicine (Baltimore). 2016 Mar;95(11):e3124. Published online 2016 Mar 18. DOI: 10.1097/MD.0000000000003124